My research and academic interests focus on the intersection of microbiology, neuroscience, and immunology—particularly how the gut microbiota influences the development and progression of neurodegenerative diseases such as Alzheimer’s and Parkinson’s. I am also interested in exploring microbiome-based therapeutic strategies, including probiotics, prebiotics, and fecal microbiota transplantation, as potential interventions. In addition, I have a growing interest in genome editing technologies such as CRISPR-Cas9, especially in the context of studying gene-microbiome interactions and developing targeted treatments for complex diseases. My broader academic interests include molecular biology, immunotherapy, cancer biology, and translational medicine, with a goal of bridging basic research and clinical application.
My research and academic interests focus on the intersection of microbiology, neuroscience, and immunology—particularly how the gut microbiota influences the development and progression of neurodegenerative diseases such as Alzheimer’s and Parkinson’s. I am also interested in exploring microbiome-based therapeutic strategies, including probiotics, prebiotics, and fecal microbiota transplantation, as potential interventions. In addition, I have a growing interest in genome editing technologies such as CRISPR-Cas9, especially in the context of studying gene-microbiome interactions and developing targeted treatments for complex diseases. My broader academic interests include molecular biology, immunotherapy, cancer biology, and translational medicine, with a goal of bridging basic research and clinical application.